Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $98.7500 (-4.89%) ($98.7500 - $104.6000) on Tue. Dec. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.93% (three month average) | RSI | 68 | Latest Price | $98.7500(-4.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.1% a day on average for past five trading days. | Weekly Trend | LGND advances 5.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) XBI(51%) IWC(50%) | Factors Impacting LGND price | LGND will decline at least -1.465% in a week (0% probabilities). VIXM(-24%) UUP(-17%) VXX(-15%) UNG(-3%) USO(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.465% (StdDev 2.93%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $103.53(-4.62%) | 10 Day Moving Average | $101.14(-2.36%) | 20 Day Moving Average | $95.45(3.46%) | To recent high | -6.9% | To recent low | 22.9% | Market Cap | $1.587b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |